噻托溴铵奥达特罗能倍乐的价格

Tiotropium olodaterol was developed by Boehringer Ingelheim and is mainly used to treat chronic obstructive pulmonary disease (COPD) in adults. Each box has a specification of 60 puffs/bottle + 1 Respirnt inhalation device. The spray is for inhalation only, and the recommended dose for adults is to inhale 2 puffs once a day at the same time through the Resplmat inhalation device.

Tiotropium bromide, olodaterol, and Respimat are long-acting anticholinergic drugs that have selective inhibitory effects on M3 receptors. They have the advantages of long blood concentration maintenance and minimal side effects. It should be noted that Respimat is contraindicated in patients with allergic reactions to tiotropium bromide, atropine or their derivatives, such as ipratropium bromide or oxotropium bromide, or the excipient lactose of this product.

In the human airway, tiotropium bromide, olodaterol, and repimat have a high affinity for receptors and dissociate slowly from muscarinic M1 and M3 receptors, which can block cholinergic nerve-mediated contraction of bronchial smooth muscle for a long time. However, Respimat dissociates from the muscarinic M2 receptor quite quickly, thus showing unique kinetic selectivity for M1 and M3 receptors.

Tiotropium bromide, olodaterol and Respimat have been on the market internationally for a long time, and the current price is not particularly high, with the price per box being around 170$. If the patient does not know how to purchase this medicine, he or she can consult a medical companion for detailed information.

Avoid spraying tiotropium and olodaterol into the eyes and avoid overdosing during treatment. The most common adverse reactions during treatment are dry mouth and cough, with an incidence rate of no more than 15%. Patients do not need to worry too much. In daily life, patients should also quit smoking and avoid passive smoking, and strengthen respiratory function exercises.

Recommended related hot articles: /newsDetail/83808.html